156 related articles for article (PubMed ID: 26365879)
1. The genomic landscape of epithelioid sarcoma cell lines and tumours.
Jamshidi F; Bashashati A; Shumansky K; Dickson B; Gokgoz N; Wunder JS; Andrulis IL; Lazar AJ; Shah SP; Huntsman DG; Nielsen TO
J Pathol; 2016 Jan; 238(1):63-73. PubMed ID: 26365879
[TBL] [Abstract][Full Text] [Related]
2. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
[TBL] [Abstract][Full Text] [Related]
4. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
[TBL] [Abstract][Full Text] [Related]
5. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
[TBL] [Abstract][Full Text] [Related]
6. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
7. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
[TBL] [Abstract][Full Text] [Related]
8. Prognostic determinants in epithelioid sarcoma.
Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.
Papp G; Changchien YC; Péterfia B; Pecsenka L; Krausz T; Stricker TP; Khoor A; Donner L; Sápi Z
Mod Pathol; 2013 Mar; 26(3):393-403. PubMed ID: 23174932
[TBL] [Abstract][Full Text] [Related]
10. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
[No Abstract] [Full Text] [Related]
11. Subclassification of epithelioid sarcoma with potential therapeutic impact.
Haefliger S; Chervova O; Davies C; Nottley S; Hargreaves S; Sumathi VP; Amary F; Tirabosco R; Pillay N; Beck S; Flanagan AM; Lyskjaer I
J Pathol; 2023 Aug; 260(4):368-375. PubMed ID: 37316954
[TBL] [Abstract][Full Text] [Related]
12. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1 expression in epithelioid sarcoma is regulated by miR-206, miR-381, and miR-671-5p on Both mRNA and protein levels.
Papp G; Krausz T; Stricker TP; Szendrői M; Sápi Z
Genes Chromosomes Cancer; 2014 Feb; 53(2):168-76. PubMed ID: 24327545
[TBL] [Abstract][Full Text] [Related]
14. Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
Stockman DL; Curry JL; Torres-Cabala CA; Watson IR; Siroy AE; Bassett RL; Zou L; Patel KP; Luthra R; Davies MA; Wargo JA; Routbort MA; Broaddus RR; Prieto VG; Lazar AJ; Tetzlaff MT
J Cutan Pathol; 2015 May; 42(5):308-17. PubMed ID: 25754356
[TBL] [Abstract][Full Text] [Related]
15. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
[TBL] [Abstract][Full Text] [Related]
17. Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
Raoux D; Péoc'h M; Pedeutour F; Vaunois B; Decouvelaere AV; Folpe AL
Am J Surg Pathol; 2009 Jun; 33(6):954-8. PubMed ID: 19342946
[TBL] [Abstract][Full Text] [Related]
18. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ.
Brenca M; Rossi S; Lorenzetto E; Piccinin E; Piccinin S; Rossi FM; Giuliano A; Dei Tos AP; Maestro R; Modena P
Mol Cancer Ther; 2013 Jun; 12(6):1060-72. PubMed ID: 23576573
[TBL] [Abstract][Full Text] [Related]
20. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
Rekhi B; Vogel U
APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
